Hazard ratio
Top View
- The Hazard Ratio Is Interpretable As an Odds Or a Probability Under the Assumption of Proportional Hazards David M
- Non-Inferiority Clinical Trials to Establish Effectiveness
- Estimating Power Calculations and Sample Size
- Commonly Reported Statistics & Concepts Quick Reference Sheet
- Non-Constant Hazard Ratios in Randomized Controlled Trials with Composite Endpoints
- Relative Effect Sizes for Measures of Risk
- Final Research Report
- Risk of Mortality in Patients Infected with SARS-Cov-2 Variant of Concern 202012/1: Matched Cohort Study BMJ: First Published As 10.1136/Bmj.N579 on 9 March 2021
- Virulence and Competitive Ability in an Obligately Killing Parasite
- Observer Bias in Randomized Clinical Trials with Time-To-Event Outcomes
- Effectiveness of the Pfizer-Biontech and Oxford-Astrazeneca Vaccines
- Clinical Trial Design New Investigators May 2017
- Multivariable Mortality Risk Prediction Using Machine Learning for COVID-19 Patients at Admission
- Randomized Trials Versus Observational Studies
- Statistical Methods Programmed in Metaview
- Meta-Analysis of Hazard Ratios
- Deviation from the Proportional Hazards Assumption in Randomized Phase 3 Clinical
- Sequential and Adaptive Analysis with Time-To-Event Endpoints